Barcelona, Spain: Women who are diagnosed with breast cancer in the 12 months after they have completed a pregnancy are 48% more likely to die than other young women with breast cancer according to new research to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday). [1] However, the study […]
2010
New studies on surgical options in inherited breast cancer show that drastic treatment is not always best
Barcelona, Spain: Two studies to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday) and tomorrow (Saturday), shed light on the treatment options facing women carrying the BRCA1 and BRCA2 genetic mutations which predispose them to breast cancer. In the first, Ms Annette Heemskerk-Gerritsen, a PhD student in the Department […]
Pregnancy for breast cancer survivors: meta-analysis reveals it is safe and could improve survival
Barcelona, Spain: Women who have been treated for breast cancer can choose to become pregnant and have babies, without fears that pregnancy could put them at higher risk of dying from their cancer, according to a major, new study. In a meta-analysis of 14 trials, presented today (Friday) at the seventh European Breast Cancer Conference […]
Patients requesting prophylactic mastectomies overestimate their breast cancer risk and need a ‘cooling off’ period
Barcelona, Spain: Women who have been diagnosed with breast cancer believe the risk of the disease occurring in their unaffected breast is as much as ten times higher than it actually is. As a result, they are choosing to have prophylactic mastectomies based on a false perception of increased risk, according to new research. However, […]
Researchers discover a new way to predict which breast cancer patients should be treated with anthracyclines
Barcelona, Spain: An international team of researchers has discovered a new way of detecting which breast cancer patients are going to respond best to chemotherapy that includes anthracycline antibiotics*. The research, presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Thursday), is important because, until now, there was conflicting evidence about the […]
What should be the goal of treatment in metastatic breast cancer? Patients and doctors differ in their views
Barcelona, Spain: Many patients with metastatic breast cancer believe that the primary goal in survival with new treatment should be to prolong life by at least a year over the survival they might expect from using current best therapies, a researcher will tell the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Wednesday). This […]
Greater collaboration between health care providers needed to ensure that breast cancer patients get full benefit from tamoxifen treatment
Barcelona, Spain: Recently published research has shown that some breast cancer patients taking tamoxifen may not be getting the full benefit of their treatment because they have also been taking selective serotonin reuptake inhibitors (SSRIs), prescribed drugs that inhibit the effect of an important enzyme. Now researchers have developed a strategy for overcoming this problem, […]
Breast cancer and socioeconomic status: worse outcomes for women from poorer backgrounds are not due to late diagnosis alone
Barcelona, Spain: The largest study in Europe to look at the link between socioeconomic status and survival after breast cancer has found that women from poorer backgrounds have worse outcomes and that this is only partly explained by more advanced cancer at diagnosis. Although other studies have found that lower socioeconomic status is linked with […]
Health professionals need to address fertility issues in young women with breast cancer in order for them to make informed decisions
Barcelona, Spain: At a time when more and more young women are surviving breast cancer and delaying childbirth, it is important to take their needs and wishes about their future fertility into consideration when deciding on treatment, the seventh European Breast Cancer Conference (EBCC7) in Barcelona will hear today (Wednesday). Dr. Anne Armstrong, from the […]
Recurrence of breast cancer after more than ten years is an important indicator of survival
Barcelona, Spain: Recurrence of breast cancer in the same area as the original tumour remains the strongest, independent prognostic factor for subsequent metastasis and death, even for patients who have been free of disease for a very long time, according to research presented today (Wednesday) at the seventh European Breast Cancer Conference (EBCC7). Dr Sven […]